Evidence map›Paper›PMID 35453995›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Implications of Myocardial Bridge on Coronary Atherosclerosis and Survival.

Roxana Oana Darabont, Ionela Simona Vișoiu, Ștefania Lucia Magda, Claudiu Stoicescu, Vlad Damian Vintilă, Cristian Udroiu, Dragoș Vinereanu

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Myocardial Bridge: Friend, Enemy, or Frenemy?Arquivos brasileiros de cardiologia · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Roxana Oana DarabontDepartment of Cardiology and Cardiovascular Surgery, University of Medicine and Pharmacy "Carol Davila", 37 Dionisie Lupu, 030167 Bucharest, Romania.ORCID 0000-0002-8231-3603
Ionela Simona VișoiuDepartment of Cardiology, University Emergency Hospital of Bucharest, 169 Splaiul Independenței, 050098 Bucharest, Romania.ORCID 0000-0001-7601-671X
Ștefania Lucia MagdaDepartment of Cardiology and Cardiovascular Surgery, University of Medicine and Pharmacy "Carol Davila", 37 Dionisie Lupu, 030167 Bucharest, Romania.
Claudiu StoicescuDepartment of Cardiology and Cardiovascular Surgery, University of Medicine and Pharmacy "Carol Davila", 37 Dionisie Lupu, 030167 Bucharest, Romania.ORCID 0000-0002-2686-8778
Vlad Damian VintilăDepartment of Cardiology and Cardiovascular Surgery, University of Medicine and Pharmacy "Carol Davila", 37 Dionisie Lupu, 030167 Bucharest, Romania.
Cristian UdroiuDepartment of Cardiology, University Emergency Hospital of Bucharest, 169 Splaiul Independenței, 050098 Bucharest, Romania.
Dragoș VinereanuDepartment of Cardiology and Cardiovascular Surgery, University of Medicine and Pharmacy "Carol Davila", 37 Dionisie Lupu, 030167 Bucharest, Romania.
Carol Davila University of Medicine and Pharmacy · ROClinical Emergency Hospital Bucharest · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In this study, we aimed to describe the impact of MBs on atherosclerosis and survival, in patients with coronary artery disease (CAD). Methods: We retrospectively studied 1920 consecutive patients who underwent conventional coronary angiography for suspected CAD. Atherosclerotic load (AL), defined as the sum of degrees of stenosis, and general atherosclerotic load (GAL), representing the sum of AL, were compared between patients with MB and a control group without MB; patients in these groups were similar in age and sex. We assessed survival at 10 years after the last enrolled patient. Results: Prevalence of MB was 3.96%, predominantly in the mid-segment of left anterior descendent artery (LAD). In the presence of MB, GAL was lower (158.1 ± 93.7 vs. 205.3 ± 117.9, p = 0.004) with a lesser AL in the proximal (30.3 ± 39.9 vs. 42.9 ± 41.1, p = 0.038) and mid-segments (8.1 ± 20.0 vs. 25.3 ± 35.9, p < 0.001) of LAD. Based on a Multinominal Logistic Regression, we found that the presence of MB on LAD (regardless of its location on this artery) is a protective factor against atherosclerotic lesions, decreasing the probability of significant stenosis, especially of those ≥70%, on the entire artery (B −1.539, OR 4660; 95% CI = 1.873−11.595, p = 0.001) and on each of its segments as well: proximal LAD (B −1.275, OR 0.280; 95% CI = 0.015−5.073; p = 0.038), mid-LAD (B −1.879, OR 6.545; 95% CI = 1.492−28.712; p = 0.013) and distal LAD (B −0.900, OR 2.459, 95% CI = 2.459−2.459, p = 0.032). However, 10-year survival was similar between groups (76.70% vs. 74.30%, p = 0.740). Conclusion: The presence of MB on LAD proved to be a protective factor against atherosclerosis for the entire artery and for each of its segments, but it does not influence long-term survival in patients with CAD.

Indexed as

atherosclerosismyocardial bridgesurvival

Identifiers

PMID35453995
PMCPMC9026775
OpenAlexW4223428914

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.